Search results

Crohn's Disease Forum

Help Support Crohn's Disease Forum:

  1. Crohn2357

    Anti-MAP Therapy Support Group

    The Crohn’s Vaccine Timelines are current best estimates and are not set in stone. Delays are commonplace in research due to the unpredictable nature of organising and running trials (last updated 09/10/2019). Progress The Crohn’s MAP Vaccine is being developed and commercialized by...
  2. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    kiny, what do you think about this? Could you share your thoughts? Segal AW. Making sense of the cause of Crohn’s – a new look at an old disease [version 2; peer review: 2 approved]. F1000Research 2016, 5:2510 (https://doi.org/10.12688/f1000research.9699.2) These are the last three articles...
  3. Crohn2357

    Anti-MAP Therapy Support Group

    RedHill Announces Full Results from MAP US Phase 3 Study and Supportive Top-Line Results from MAP US2 Study with RHB-104 in Crohn’s Disease 11 October, 2019 TEL-AVIV, Israel and RALEIGH, N.C., October 11, 2019 RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or...
  4. Crohn2357

    Anti-MAP Therapy Support Group

    Crohn's MAP Vaccine September 2019 newsletter ']View this email in your browser Research update Vaccine Trials Progress: Phase II Clinical Trial in people with Crohn's disease: Drumroll… We are excited to report that the Phase II trial in Crohn’s disease has...
  5. Crohn2357

    Anti-MAP Therapy Support Group

    https://www.crohnsforum.com/threads/the-dangers-using-the-wrong-antibiotics-that-are-ineffective-against-aiec.85337/
  6. Crohn2357

    Qu Biologics study

    I agree with this.
  7. Crohn2357

    Anti-MAP Therapy Support Group

    https://www.crohnsforum.com/threads/redhills-latest-press-release-clearly-shows-their-rhb104-phase-3-results.85319/
  8. Crohn2357

    Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naïve Patients with Crohn’s Disease

    Why was this moved to the general discussion subforum from the research subforum? This is strictly a research article. Also, I haven’t had any notifications about the moving of this and the other research threads I posted, which were also strictly research and news articles.
  9. Crohn2357

    New Drug - Mirikizumab

    https://www.pmlive.com/pharma_news/latecomer_lilly_preps_its_il-23_drug_for_crohns_disease_1288959?SQ_DESIGN_name=2&
  10. Crohn2357

    Double-biologic therapy with Entyvio to control extra-intestinal symptoms

    https://crohnsforum.com/threads/vedolizumab-brings-endoscopic-remission-in-some-patients-with-crohns-disease.85221/
  11. Crohn2357

    Smoked salmon?

    It's a reaction to the high levels of histamine found in smoked fish. https://food.r-biopharm.com/news/histamine-intolerance-fish/
  12. Crohn2357

    Double-biologic therapy with Entyvio to control extra-intestinal symptoms

    @MLP, has your son tried sulfasalazine for the arthritis?
  13. Crohn2357

    Using Stem Cells To Treat Perianal Fistulas

    Prevalence of Fistulizing Crohn’s Disease in the United States: Estimate From a Systematic Literature Review Attempt and Population-Based Database Analysis David A Schwartz, MD, Ignacio Tagarro, PhD, Mary Carmen Díez, MD, William J Sandborn, MD Inflammatory Bowel Diseases...
  14. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    Some research and links: The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosis https://www.sciencedaily.com/releases/2019/03/190305112836.htm https://www.cedars-sinai.org/newsroom/daily-mail-dandruff-could-be-key-to-crohns-disease/...
  15. Crohn2357

    The IBD Therapeutic Pipeline is Primed to Produce

    https://discovertherapies.com/articles/71-what-new-therapies-for-crohn-s-and-colitis-can-we-expect
  16. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    How do researches who think CD is an autoimmune disorder explain the existence of granulomas in CD, do you know?
  17. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    @kiny, could you elaborate your thoughts on the significance of granulomatous inflammation in CD's aetiology?
  18. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    @kiny, could you put the oral aphthous ulcers seen at the onset of Crohn's into a perspective? I had them right before my diagnosis. After I got hospitalised, diagnosed and received treatment, they were immediately gone and they never recurred; even though I have never been in remission for...
Back
Top